PHASE-II EVALUATION OF PHENESTERIN IN PATIENTS WITH ADVANCED OVARIAN-CANCER

被引：0
|
作者：
BLOOM, RE
POLIVOGIANIS, L
DAVIS, TE
BENNETT, JM
HORTON, J
机构：
[1] UNIV ROCHESTER,CTR CANC,ROCHESTER,NY 14642
[2] DANA FARBER CANC INST,BOSTON,MA
[3] WISCONSIN CLIN CANC CTR,MADISON,WI
[4] UNION UNIV ALBANY MED COLL,ALBANY,NY 12208
[5] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[6] AMER ONCOL HOSP,PHILADELPHIA,PA 19111
[7] UNIV HLTH SCI CHICAGO MED SCH,CHICAGO,IL 60612
[8] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,PHILADELPHIA,PA 19107
[9] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901
[10] MED COLL OHIO,TOLEDO,OH 43699
[11] NORTHWESTERN UNIV,MED CTR,CHICAGO,IL 60611
[12] UNIV PITTSBURGH,PITTSBURGH,PA 15260
[13] RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612
[14] TUFTS UNIV,WALPOLE,MA
[15] NATALIE WARREN BRYANT CANC CTR,TULSA,OK
[16] YALE UNIV,SCH MED,NEW HAVEN,CT 06510
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：601 / 602
页数：2
相关论文
共 50 条
  • [1] PHASE-II EVALUATION OF BLEOMYCIN IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER
    BLACKLEDGE, G
    LAWTON, F
    BUCKLEY, H
    CROWTHER, D
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 549 - 550
  • [2] PHASE-II STUDY OF AMSA IN PATIENTS WITH ADVANCED OVARIAN-CANCER
    KEARSLEY, JH
    COATES, AS
    FOX, RM
    TATTERSALL, MHN
    PAGE, J
    LEVI, JA
    CANCER TREATMENT REPORTS, 1982, 66 (05): : 1242 - 1243
  • [3] PHASE-II EVALUATION OF MITOZOLOMIDE IN OVARIAN-CANCER
    HARDING, M
    NORTHCOTT, D
    SMYTH, J
    STUART, NSA
    GREEN, JA
    NEWLANDS, E
    BRITISH JOURNAL OF CANCER, 1988, 57 (01) : 113 - 114
  • [4] PHASE-II TRIAL OF INTRAVENOUS HEXAMETHYLMELAMINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER
    HAUGE, MD
    LONG, HJ
    HARTMANN, LC
    EDMONSON, JH
    WEBB, MJ
    SU, J
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (04) : 299 - 301
  • [5] A PHASE-II EVALUATION OF VP16-213 IN ADVANCED OVARIAN-CANCER
    HILLCOAT, B
    BISHOP, J
    CAMPBELL, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 215 - 215
  • [6] PHASE-II CLINICAL-TRIAL OF DOXIFLURIDINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER
    VANOOSTEROM, AT
    HUININK, WWT
    VANDERBURG, MEL
    VERMORKEN, JB
    WILLEMSE, PHB
    NEIJT, JP
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) : 747 - 749
  • [7] PHASE-II STUDY OF VINBLASTINE AND BLEOMYCIN IN ADVANCED OVARIAN-CANCER
    OSBORNE, RJ
    HARVEY, VJ
    SLEVIN, ML
    SHEPHERD, JH
    WILLIAMS, CJ
    CANCER TREATMENT REPORTS, 1987, 71 (03): : 335 - 336
  • [8] CARBOPLATIN IN COMBINATION WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A PHASE-II STUDY
    ANDERSSON, H
    FRIBERG, LG
    HORVATH, G
    JOHANSSON, O
    AKESSON, M
    WESTBERG, R
    ACTA ONCOLOGICA, 1995, 34 (06) : 821 - 827
  • [9] PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH PLATINUM-REFRACTORY ADVANCED OVARIAN-CANCER
    FRANCIS, P
    SCHNEIDER, J
    HANN, L
    BALMACEDA, C
    BARAKAT, R
    PHILLIPS, M
    HAKES, T
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2301 - 2308
  • [10] A PHASE-II CLINICAL-TRIAL OF CARBOPLATIN IN ADVANCED OVARIAN-CANCER
    POHL, J
    MEERPOHL, HG
    PFLEIDERER, A
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 61 - 61
12345